US.RMD · ResMed

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.666727181954341,
        "turnoverUsdM": 246.77775221000002,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.RMD",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 204.1722,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 7.3,
      "take_profit_price": 238.7499,
      "target_multiplier": 1.9,
      "technical_strength": 1.8,
      "take_profit_percent": 8.4
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.333454363908682,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 71,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 66,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 213.085,
    "ma50": 204.321,
    "close": 220.33,
    "prevClose": 224.46,
    "avgVolume20": 1415102,
    "volumeRatio": 0.79,
    "changePercent": -1.84
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": 0.00127242443164155,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 0.7938092015039353,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.802614107344578,
      "volat_points": 0,
      "day_range_pct": 0.023986747151999256,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 71,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 86,
        "contribution": 4.3
      },
      {
        "raw": 14.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 74,
        "contribution": 14.8
      },
      {
        "raw": 11,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 73.33,
        "contribution": 11
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 5.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 57,
        "contribution": 5.7
      },
      {
        "raw": 20.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 67.33,
        "contribution": 20.2
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 66,
    "details": [
      "基本面分析總分: 4.3/5分",
      "資金流分析總分: 14.8/20分",
      "市場環境分析總分: 11/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 5.7/10分",
      "技術信號分析總分: 20.2/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 4.3,
      "資金流": 14.8,
      "市場環境": 11,
      "情緒分析": 4,
      "技術信號": 20.2,
      "風險管理": 5.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.75,
          "turnoverUsdM": 246.77775221000002,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 4,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.RMD",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.25
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 705.8159980000001,
                "ma50": 712.735402,
                "name": "QQQ",
                "close": 729.87,
                "points": 1.4
              },
              "spy": {
                "ma20": 757.7255032499999,
                "ma50": 749.238004,
                "name": "SPY",
                "close": 772.66998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.666727181954341,
          "atrPoints": 2,
          "cciPoints": 3.2,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141202371,
                "url": "https://finnhub.io/api/news?id=a14265c9592c375e48e5eb528b975618d736e006f258f344b092ca3a052a5fc6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a discount to what the underlying cash flows may justify. ResMed has returned 26.3% over the past 3 years, which suggests that longer term holders have still seen gains despite the recent share price weakness. Recent pressure around a softer outlook and suspended ventilator sales can weigh on sentiment, while...",
                "category": "company",
                "datetime": 1786529545,
                "headline": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook"
              },
              {
                "id": 141202372,
                "url": "https://finnhub.io/api/news?id=ac834b7859cf4b846702996dda6c6e37f63e3abb547173b38d11e3b8ddae9292",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer fiscal 2027 outlook tied to suspended ventilator sales after an FDA Class 1 recall and ongoing cost pressures, sharpening investor focus on how resilient ResMed’s broader sleep-health and...",
                "category": "company",
                "datetime": 1786502030,
                "headline": "Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?"
              },
              {
                "id": 141172251,
                "url": "https://finnhub.io/api/news?id=f2063936d03cb19961ca791af5534a8c650f80d3788699052506252a8fba69ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786340002,
                "headline": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts"
              },
              {
                "id": 141149640,
                "url": "https://finnhub.io/api/news?id=9330c5d081238104a84cc1a9ddf25b5c9eb1eb96172fe7a4c6eb81db3d1c6b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.",
                "category": "company",
                "datetime": 1786115520,
                "headline": "RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y"
              },
              {
                "id": 141144733,
                "url": "https://finnhub.io/api/news?id=e26f47ae823ecc252f5680e158079bb8a60f3037a644a23f92ff40536cfbfebf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed Inc (RMD) delivers 9% revenue growth and 16% EPS growth in Q4 FY2026, while navigating Astral-related challenges and guiding to 5-7% core growth for FY2027.",
                "category": "company",
                "datetime": 1786079567,
                "headline": "ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ..."
              },
              {
                "id": 141143188,
                "url": "https://finnhub.io/api/news?id=07e7ea94ce7a8f216624befb92fb3e600fa186c7ba568ef257a838dec6539b5e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "ResMed Inc. (RMD) Q4 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsSallilyn Schwartz - Chief Investor Relations OfficerMichael Farrell -...",
                "category": "company",
                "datetime": 1786053258,
                "headline": "ResMed Inc. (RMD) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141142416,
                "url": "https://finnhub.io/api/news?id=6f2d99ac4b464c82a818cf0692813ffcce8906c93fba111d3986dafdfc43bc5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786052824,
                "headline": "ResMed (NYSE:RMD) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops"
              },
              {
                "id": 141142417,
                "url": "https://finnhub.io/api/news?id=f9835639451fee0e6b3630315db2f0c70a6a253a6d8916bc5d7a11ff366e728e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) delivered earnings and revenue surprises of +1.72% and +0.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786052409,
                "headline": "ResMed (RMD) Q4 Earnings and Revenues Top Estimates"
              }
            ],
            "raw_source": [
              {
                "id": 141231506,
                "url": "https://finnhub.io/api/news?id=9d892d1c46fc34e76484400133ccfacd3aaf49d29a7d83b06d9eef6c6da6ce1f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1562199023/image_1562199023.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "Weekly dividend stock updates: 21 hikes, 1 cut, 1 special. See top picks BR, CSL & RMD—quality, safety and undervaluation.",
                "category": "company",
                "datetime": 1786873045,
                "headline": "Dividend Announcements: August 1-7, 2026"
              },
              {
                "id": 141220362,
                "url": "https://finnhub.io/api/news?id=aca754d054c2cc29e122e29d60fc10d0d806a9a9424655c9d9e085ef4de25d34",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "Weekly dividend summary for Dividend Champions, Contenders & Challengers—read the full list of dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1786730477,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week August 16"
              },
              {
                "id": 141192693,
                "url": "https://finnhub.io/api/news?id=1a51c3fda625137f05bd7a8622dd3db9cd4f97aa3ff563d6f1aa5511d9562da4",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.",
                "category": "company",
                "datetime": 1786538101,
                "headline": "Which S&P500 stocks are moving before the opening bell on Wednesday?"
              },
              {
                "id": 141202371,
                "url": "https://finnhub.io/api/news?id=a14265c9592c375e48e5eb528b975618d736e006f258f344b092ca3a052a5fc6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a discount to what the underlying cash flows may justify. ResMed has returned 26.3% over the past 3 years, which suggests that longer term holders have still seen gains despite the recent share price weakness. Recent pressure around a softer outlook and suspended ventilator sales can weigh on sentiment, while...",
                "category": "company",
                "datetime": 1786529545,
                "headline": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook"
              },
              {
                "id": 141202372,
                "url": "https://finnhub.io/api/news?id=ac834b7859cf4b846702996dda6c6e37f63e3abb547173b38d11e3b8ddae9292",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer fiscal 2027 outlook tied to suspended ventilator sales after an FDA Class 1 recall and ongoing cost pressures, sharpening investor focus on how resilient ResMed’s broader sleep-health and...",
                "category": "company",
                "datetime": 1786502030,
                "headline": "Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?"
              },
              {
                "id": 141202373,
                "url": "https://finnhub.io/api/news?id=7c4506bd336d7052bb2aa2945f9f087fdc744710d9111a84d3688d4b0a575537",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.",
                "category": "company",
                "datetime": 1786465380,
                "headline": "Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists"
              },
              {
                "id": 141202374,
                "url": "https://finnhub.io/api/news?id=c9a55f0c358b934750870cb43810aa47c1355f539cbb188366e6b5733580ef3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.",
                "category": "company",
                "datetime": 1786465320,
                "headline": "Should Investors Buy Inogen as Low Valuation Meets Execution Risk?"
              },
              {
                "id": 141173748,
                "url": "https://finnhub.io/api/news?id=36ece7701581afbc0c45cf4c64a289371a52775d64bb8b21d154e5aa1ad1a304",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.",
                "category": "company",
                "datetime": 1786360137,
                "headline": "Resmed’s stock falls by 7% on soft FY27 outlook"
              },
              {
                "id": 141172251,
                "url": "https://finnhub.io/api/news?id=f2063936d03cb19961ca791af5534a8c650f80d3788699052506252a8fba69ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786340002,
                "headline": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts"
              },
              {
                "id": 141164496,
                "url": "https://finnhub.io/api/news?id=a45c6768cb0a925167bb2caabc3e4fdcc136f4362e935257ea82e41483442ced",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electroni",
                "category": "company",
                "datetime": 1786248229,
                "headline": "ResMed Q4 Earnings Call Highlights"
              },
              {
                "id": 141164828,
                "url": "https://finnhub.io/api/news?id=67a12f998d09e3a8032fc7543984727ae385b02a09472666c7971ce61d490975",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215519735/image_2215519735.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. Check out the list here.",
                "category": "company",
                "datetime": 1786243803,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For August 2026"
              },
              {
                "id": 141150616,
                "url": "https://finnhub.io/api/news?id=97cc30b60f13c7af214f0c0afb17997cc515ad12a36ad63fdf4d3ec954ca3f5c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1786129501,
                "headline": "Stay informed with the top movers within the S&P500 index on Friday."
              },
              {
                "id": 141152423,
                "url": "https://finnhub.io/api/news?id=af72a397d825898b459a1a054ad11e152f22a3d67f610472c2aab599efe41d41",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "Weekly dividend activity roundup for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1786125278,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 9"
              },
              {
                "id": 141149003,
                "url": "https://finnhub.io/api/news?id=ef9e2796d2ec153c86f76a0efc5f8a7f4a4eab218d749fcd6a3713e33e419366",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Friday's session.",
                "category": "company",
                "datetime": 1786122300,
                "headline": "In today's session, there are S&P500 stocks with remarkable trading volume."
              },
              {
                "id": 141148910,
                "url": "https://finnhub.io/api/news?id=9bdba43fcab22b2cbe6b2e92788d4e69dd55e6b163385f9dbbc531c0004beafd",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.",
                "category": "company",
                "datetime": 1786120501,
                "headline": "Top S&P500 movers in Friday's session"
              },
              {
                "id": 141153610,
                "url": "https://finnhub.io/api/news?id=162e6edef4356f7eb0c7235270c0972716ca4d6de76862bbf7006d9764dc6d8b",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "RBC Capital  analyst Craig Wong-Pan   maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $234 to $244.",
                "category": "company",
                "datetime": 1786119093,
                "headline": "RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244"
              },
              {
                "id": 141149640,
                "url": "https://finnhub.io/api/news?id=9330c5d081238104a84cc1a9ddf25b5c9eb1eb96172fe7a4c6eb81db3d1c6b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.",
                "category": "company",
                "datetime": 1786115520,
                "headline": "RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y"
              },
              {
                "id": 141147567,
                "url": "https://finnhub.io/api/news?id=ba7e0c36628e3e622f779f9a6b4fcefb13ededca266f41f5382d1d7a360c7967",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1786113301,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 141149831,
                "url": "https://finnhub.io/api/news?id=ed83215398feaf5df6a377a600ecc89fd18ace8239fcbfea60c662d7e787cdcb",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/SP-500.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "U.S. payrolls fell 23,000 in July, gutting September Fed hike odds. The S&P 500 hit a record, while gold jumped to a seven-week high.",
                "category": "company",
                "datetime": 1786109247,
                "headline": "S&P 500 Hits Record As Jobs Shock Sinks Rate-Hike Bets: Stock Market Today"
              },
              {
                "id": 141153612,
                "url": "https://finnhub.io/api/news?id=e1469dc4cf1a9b93443bc8bde6236da05ac919be746cb5a96c540e9b8973bcff",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Piper Sandler  analyst Adam Maeder   maintains ResMed (NYSE:RMD) with a Neutral and lowers the price target from $233 to $225.",
                "category": "company",
                "datetime": 1786108086,
                "headline": "Piper Sandler Maintains Neutral on ResMed, Lowers Price Target to $225"
              },
              {
                "id": 141147080,
                "url": "https://finnhub.io/api/news?id=fb38d0e669c6ebb7a77e00e1f4b64b1991a2b958d779c41b6078dc5f53e51b92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "(Updates with economic data, recent oil price movement, world markets' overview and corporate stock",
                "category": "company",
                "datetime": 1786107416,
                "headline": "Update: US Equity Futures Rise Pre-Bell as Traders Assess Jobs Report, Monitor Middle East Developments"
              },
              {
                "id": 141147229,
                "url": "https://finnhub.io/api/news?id=f5260272055fee7d9ab541f25d669d7f9cdde5e74466a245840c9fcc7e6a19f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (NYSE:RMD) shares declined 5. 5% in premarket trading after the medical device manufacturer reported fourth-quarter fiscal 2026 results that delivered an earnings beat but fell slightly short on revenue.",
                "category": "company",
                "datetime": 1786106465,
                "headline": "ResMed Shares Fall After Revenue Miss and Conservative 2027 Outlook"
              },
              {
                "id": 141146666,
                "url": "https://finnhub.io/api/news?id=073c54ac6a5c9a52cf67af390cc14433ee433ae80c98f88141a2bf1f9b5787c4",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1786106101,
                "headline": "Which S&P500 stocks are moving before the opening bell on Friday?"
              },
              {
                "id": 141153613,
                "url": "https://finnhub.io/api/news?id=f42af4e01184cab1b7ec516f2215779f322997ffc7c5035bf6917b5b9f0241e5",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Keybanc  analyst Brett Fishbin   maintains ResMed (NYSE:RMD) with a Overweight and lowers the price target from $260 to $255.",
                "category": "company",
                "datetime": 1786097629,
                "headline": "Keybanc Maintains Overweight on ResMed, Lowers Price Target to $255"
              },
              {
                "id": 141153614,
                "url": "https://finnhub.io/api/news?id=819e2b995fef2a78d1d9a608be1176eeb6975e3f90ffc8bd6d66e62a7b120924",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Wells Fargo  analyst Nathan Treybeck   maintains ResMed (NYSE:RMD) with a Equal-Weight and lowers the price target from $225 to $215.",
                "category": "company",
                "datetime": 1786097490,
                "headline": "Wells Fargo Maintains Equal-Weight on ResMed, Lowers Price Target to $215"
              },
              {
                "id": 141147448,
                "url": "https://finnhub.io/api/news?id=42771496d59a56028a962cf7d3e7928c840ba00554b95a93a821fabde9142024",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/Portland--Or--Usa---Jan-21--2021-The-Tra.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "US stock futures mixed, Nasdaq 100 futures up 100 points. Trade Desk Inc shares down 27.7% after weak Q2 results. Other stocks also lower premarket.",
                "category": "company",
                "datetime": 1786089735,
                "headline": "Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session"
              },
              {
                "id": 141144733,
                "url": "https://finnhub.io/api/news?id=e26f47ae823ecc252f5680e158079bb8a60f3037a644a23f92ff40536cfbfebf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed Inc (RMD) delivers 9% revenue growth and 16% EPS growth in Q4 FY2026, while navigating Astral-related challenges and guiding to 5-7% core growth for FY2027.",
                "category": "company",
                "datetime": 1786079567,
                "headline": "ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ..."
              },
              {
                "id": 141143188,
                "url": "https://finnhub.io/api/news?id=07e7ea94ce7a8f216624befb92fb3e600fa186c7ba568ef257a838dec6539b5e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "ResMed Inc. (RMD) Q4 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsSallilyn Schwartz - Chief Investor Relations OfficerMichael Farrell -...",
                "category": "company",
                "datetime": 1786053258,
                "headline": "ResMed Inc. (RMD) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141142416,
                "url": "https://finnhub.io/api/news?id=6f2d99ac4b464c82a818cf0692813ffcce8906c93fba111d3986dafdfc43bc5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786052824,
                "headline": "ResMed (NYSE:RMD) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops"
              },
              {
                "id": 141142417,
                "url": "https://finnhub.io/api/news?id=f9835639451fee0e6b3630315db2f0c70a6a253a6d8916bc5d7a11ff366e728e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) delivered earnings and revenue surprises of +1.72% and +0.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786052409,
                "headline": "ResMed (RMD) Q4 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141142998,
                "url": "https://finnhub.io/api/news?id=e266785fa8d8f2d00504ae73786d8ead1e0a5b1add3451405a963a5df2d9e061",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "2026-08-06. The following slide deck was published by ResMed Inc.",
                "category": "company",
                "datetime": 1786051868,
                "headline": "ResMed Inc. 2026 Q4 - Results - Earnings Call Presentation"
              },
              {
                "id": 141139799,
                "url": "https://finnhub.io/api/news?id=3c4e732c0a08f2d876c2a482f4d79b93814f8d2b83bdda5964d532f85e4bc1a0",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "ResMed (RMD) Q4 revenue slightly misses, EPS beats; stock dips ~2% on profit-taking despite record results and raised dividend.",
                "category": "company",
                "datetime": 1786050938,
                "headline": "ResMed (NYSE:RMD) Q4 Results Inline with Estimates; Stock Slips 1.9%"
              },
              {
                "id": 141140799,
                "url": "https://finnhub.io/api/news?id=e661e2a1607bf2ad8fcb76dbef26ff8284d18411bf61d9c0b7cc5f4dc1110ed7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Q4 revenue increased by 9% to a record $1.5 billion; up 8% on a constant currency basis Q4 GAAP diluted earnings per share up 2% to $2.64; non-GAAP diluted earnings per share up 16% to $2.95Returned $1.0 billion to shareholders through share repurchases and dividends during FY2026, an increase of more than 70% Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX:",
                "category": "company",
                "datetime": 1786046700,
                "headline": "Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026"
              },
              {
                "id": 141141984,
                "url": "https://finnhub.io/api/news?id=5ff0d18d32d01d3f09f4fc144fb8aa27a500d0047f05ed5443dde9968e6c51ad",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "ResMed (NYSE:RMD) reported quarterly earnings of $2.95 per share which beat the analyst consensus estimate of $2.89 by 2.08 percent. This is a 15.69 percent increase over earnings of $2.55 per share from the same period",
                "category": "company",
                "datetime": 1786032357,
                "headline": "ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate"
              },
              {
                "id": 141134279,
                "url": "https://finnhub.io/api/news?id=24ccbb918500a4321fa00cad22c2de330360be3abbadfb067d8963d2611deb98",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Why the upcoming ResMed earnings matter ResMed (RMD) is back in focus ahead of its forthcoming earnings report, with Wall Street projecting quarterly earnings of $2.90 per share and revenue of about $1.46b for the period. See our latest analysis for ResMed. ResMed shares have climbed in recent weeks, with a 7 day share price return of 4.55% and a 90 day share price return of 8.28%. However, the year to date share price return is still down 8.49%, and the 1 year total shareholder return has...",
                "category": "company",
                "datetime": 1786022182,
                "headline": "ResMed (RMD) Faces An Earnings Test After A Rebound That Still Looks Undervalued"
              },
              {
                "id": 141125710,
                "url": "https://finnhub.io/api/news?id=908443464c6dac93d7d144bad74f909237b4d1ce507acfbe554ffe8dd66c08d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.",
                "category": "company",
                "datetime": 1785952740,
                "headline": "Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?"
              },
              {
                "id": 141125711,
                "url": "https://finnhub.io/api/news?id=86654da613505d37a72deed55f1f4b51cbc7a004fc7b41b9e6fd5f1e19cb0c5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.",
                "category": "company",
                "datetime": 1785951300,
                "headline": "INSP's 28.1% Past-Month Rally Raises a Key Question for Investors"
              },
              {
                "id": 141122934,
                "url": "https://finnhub.io/api/news?id=5ebdc3970abbb2a2338a21c3afa648199e0f3a8e8c03b36dd04d8ac65b339e0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, inflation and hospital spending pressures.",
                "category": "company",
                "datetime": 1785941820,
                "headline": "What to Expect From These 2 MedTech Stocks This Earnings Season?"
              },
              {
                "id": 141122755,
                "url": "https://finnhub.io/api/news?id=679dc62b0d6341e0716993d69a4659ffa37cff052797d6fbc10f1828108e701d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Evaluate the expected performance of ResMed (RMD) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1785935706,
                "headline": "Curious about ResMed (RMD) Q4 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141104327,
                "url": "https://finnhub.io/api/news?id=352cc05ac2d4a26c5635f6fdf97bc1040f7f84f82a959edb3181f428a871c81d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Viemed Healthcare (VMD) delivered earnings and revenue surprises of -30.00% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785797109,
                "headline": "Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates"
              },
              {
                "id": 141103236,
                "url": "https://finnhub.io/api/news?id=124e694ad0b3e2f69b544333b87c4d5251ef48d8bf142f9f9ca9f8ba16d24cdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1785788962,
                "headline": "1 Cash-Producing Stock on Our Watchlist and 2 We Find Risky"
              },
              {
                "id": 141079192,
                "url": "https://finnhub.io/api/news?id=ba7731a4b95a73e9b539fb9155adffe31e1dea22943a4c45be8f8fa12e57990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "RMD's Q4 results may reflect strong mask and device demand, portfolio innovation, acquisitions and digital health growth, with EPS seen rising 13.7%.",
                "category": "company",
                "datetime": 1785504720,
                "headline": "Resmed's Q4 Earnings on Deck: What's in Store for the Stock?"
              },
              {
                "id": 141078062,
                "url": "https://finnhub.io/api/news?id=eccab60418f61c40d3a156f57c0957bf7084f81ce29971339390e78da2a7b84d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1785504709,
                "headline": "3 Large-Cap Stocks to Consider Right Now"
              },
              {
                "id": 141067141,
                "url": "https://finnhub.io/api/news?id=2eba5c1a1a25c1b0f492d696ae339d2d6665a3f0234260cb85aab3bb8fd081ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420019,
                "headline": "ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 141065678,
                "url": "https://finnhub.io/api/news?id=627351a5866f253bd786f5ad7587b3fed6c6ee8ec3bbe68f04ebc325dd60a5ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Baxter (BAX) delivered earnings and revenue surprises of +55.56% and +5.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785414903,
                "headline": "Baxter International (BAX) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 140991410,
                "url": "https://finnhub.io/api/news?id=a7d3773d8f60001c539390370a53abf66180cc30e499445d40c79aec749bde17",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital.",
                "category": "company",
                "datetime": 1784791489,
                "headline": "3 Cash-Heavy Stocks to Research Further"
              },
              {
                "id": 140973578,
                "url": "https://finnhub.io/api/news?id=d1da9496c35a7b3d8bb71682a817d89804339dc66aec5bf1446d9a2e13a70166",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) is expected to post strong fiscal Q4 earnings growth, helped by an 8.6% rise in sales a",
                "category": "company",
                "datetime": 1784653509,
                "headline": "ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 47,
            "discarded_article_count": 35
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.2,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 1517850,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1727040,
              "avg_vol_20": 1410965,
              "avg_vol_30": 1517850,
              "range_pct_10": 0.12050106658194532,
              "range_pct_20": 0.17401166432169926,
              "range_pct_30": 0.17401166432169926,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1378199426820832,
              "dist_to_20d_high": 0.03596587180048129,
              "down_shrink_days": 1,
              "breakout_level_20d": 228.55,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6924884435285459
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.666727181954341,
              "turnoverUsdM": 246.77775221000002,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.RMD",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 204.1722,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 7.3,
            "take_profit_price": 238.7499,
            "target_multiplier": 1.9,
            "technical_strength": 1.8,
            "take_profit_percent": 8.4
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.333454363908682,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 8.0789,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.67
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 61.61
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "強累積",
      "score": 10,
      "value": 0.3351
    },
    "kdj": {
      "d": 84.39,
      "j": 76.32,
      "k": 81.7,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 67.64
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 992463,
      "recentSlope": -63723.7,
      "previousSlope": 585790
    },
    "rsi": 59.5,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 214.5933,
      "position": "SAR喺價下",
      "distancePct": 2.6,
      "previousTrend": "上升"
    },
    "ma50": 204.321,
    "macd": {
      "macd": 6.035519503075278,
      "trend": "強烈看漲",
      "signal": 5.4134437154980635,
      "histogram": 0.6220757875772147
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 213.1954,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 16
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.79,
      "score": 2,
      "avgVolume": 1415102,
      "currentVolume": 1120037
    },
    "derived": {
      "ma20": 213.085,
      "ma50": 204.321,
      "prevClose": 224.46,
      "avgVolume10": 1692434,
      "avgVolume20": 1415102,
      "changePercent": -1.84,
      "avgVolumeForScore": 1415102
    },
    "ma_cross": {
      "ma20": 213.085,
      "ma50": 204.321,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 211.999,
      "prevMa50": 203.8008,
      "spreadPct": 4.29,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 189.9875,
      "upper": 236.1825,
      "position": "上半部"
    },
    "rsi_short": 69.78,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.79
    }
  }
}

{
  "close": 220.33,
  "volume": 1120037,
  "changePercent": -1.84
}